← All stocks

Greenwich LifeSciences, Inc.

GLSI Net buying

CIK 0001799788 #3849 in the set updated 17 Sep 2026

Bought (120 mo)

$8.04M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$8.04M

+$8.04M against sales at will

By person

8 insiders · 121 transactions

206×

Snehal Patel holds 206 times base salary in stock. $126.47M of shares against $612.56K in salary for 2024.

Salary from the company's own proxy. The shares are what Snehal Patel last reported holding, valued at $13.10, the price Common Stock was last bought or sold at on the open market here, on 29 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Patel Snehal

CEO and CFO

$7.27M (86)

—

+$7.27M

9,653,878

65.77%

$126.47M

+31.4%

Hallock Kenneth

Director

$484.00K (5)

—

+$484.00K

794,308

5.41%

$10.41M

+34.1%

Thompson Jaye

VP Clinical Reg Affairs

$164.78K (21)

—

+$164.78K

264,148

1.80%

$3.46M

+4.4%

Daugherty Frank Joseph

Chief Medical Officer

$81.32K (5)

—

+$81.32K

90,121

0.6140%

$1.18M

+6.9%

McWilliams David

Director

$28.61K (3)

—

+$28.61K

620,301

4.23%

$8.13M

+39.6%

Rothe Eric

Director

$10.80K (1)

—

+$10.80K

313,226

2.13%

$4.10M

+0.6%

Patel Kinnary

10% owner

—

1,329,590

9.06%

$17.42M

+10.8%

Patel Pankaj Amrit

10% owner

—

0.0000%

$0.00

−100.0%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 135

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 2,644,519

History held since 29 Sep 2020